1. Home
  2. AVX vs YI Comparison

AVX vs YI Comparison

Compare AVX & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AVX

Avax One Technology Ltd.

N/A

Current Price

$0.60

Market Cap

63.3M

Sector

Industrials

ML Signal

N/A

Logo 111 Inc.

YI

111 Inc.

HOLD

Current Price

$6.60

Market Cap

57.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVX
YI
Founded
2017
2010
Country
Canada
China
Employees
3
N/A
Industry
Metal Fabrications
Retail-Drug Stores and Proprietary Stores
Sector
Industrials
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
57.1M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
AVX
YI
Price
$0.60
$6.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
337.2K
12.5K
Earning Date
05-14-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$2.48
52 Week High
$2.27
$11.17

Technical Indicators

Market Signals
Indicator
AVX
YI
Relative Strength Index (RSI) 46.53 49.49
Support Level $0.55 $6.13
Resistance Level $0.84 $7.18
Average True Range (ATR) 0.07 0.38
MACD 0.01 0.03
Stochastic Oscillator 47.79 42.86

Price Performance

Historical Comparison
AVX
YI

About AVX Avax One Technology Ltd.

AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.

About YI 111 Inc.

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.

Share on Social Networks: